Business & Industry
Business & Industry
Asia’s CROs VCs: Blurring Service Provider & Investor Roles
In a time characterized by accelerated innovation and ever-more complicated clinical environments, Asia is witnessing an invigorating shift in the role of Contract Research Organizations (CROs). Once seen as service organizations that assist in the pharmaceutical and biotech product...
Business & Industry
API China, PHARMCHINA & NHNE 2025 Conclude with Global Win
API China, PHARMCHINA & NHNE 2025 Close in Guangzhou with Thumping Success, Solidifying China as a World Pharma Leader
Guangzhou, May 24, 2025 — In a strong demonstration of innovation, industrial synergy, and global cooperation, the 92nd API China, 90th...
Business & Industry
API China 2025 kicks off with Industry Buzz on Day One
At the China Import and Export Fair Complex in Guangzhou, the 92nd edition of API China, the country's leading pharmaceutical trade fair, got off to a lively start. This industry-leading event, which is co-located with PHARMEX, PHARMPACK, and SINOPHEX,...
Business & Industry
Regulatory Changes in Europe Impact APIs and Excipients
There have been big changes in the pharmaceutical industry because of regulatory changes in Europe that are meant to make drugs safer, more effective, and last longer. Specialised excipients and active pharmaceutical ingredients (APIs), which are important parts of...
Business & Industry
EU Green Regulations Impact Pharmaceutical Chemical Industry
Pharma specialty chemicals companies have been experiencing serious challenges based on the greening regulations enforced by the European Union. Such regulatory systems promote the harmonization of environmental stewardship and industrial development, yet they have become complex for the specialty...
Business & Industry
Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn
The Purification & Filtration division manufactures filters and membranes for biopharmaceutical and medical technologies, microelectronics, food and beverage goods, and drinking water. It employs over 2,500 people worldwide and has locations in the Americas, Europe, the Middle East, Africa,...
Business & Industry
Lundbeck pharma acquires Prexton Therapeutics in EUR905m deal
Danish pharma company H. Lundbeck has agreed to acquire Switzerland-based Prexton Therapeutics, which develops drugs for Parkinson's disease and other brain disorders, in a deal worth about DKK6.75bn (€905m). As per the agreement terms, Lundbeck will pay an upfront...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read